These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2346124)

  • 1. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Malfetano J
    Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
    Muss HB; Blessing JA; Eddy GL; McGehee R
    Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Hanjani P; Malfetano JH; Kemp GM; Webster K
    Am J Clin Oncol; 1992 Aug; 15(4):363-4. PubMed ID: 1325110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echinomycin (NSC 526417) in advanced ovarian cancer. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Baker VV; Barnhill DR; Adelson MD
    Am J Clin Oncol; 1990 Aug; 13(4):299-301. PubMed ID: 2198794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echinomycin in recurrent and metastatic endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; DuBeshter B
    Am J Clin Oncol; 1993 Dec; 16(6):492-3. PubMed ID: 8256763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Malfetano JH; Blessing JA; Homesley HD; Hanjani P
    Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study.
    Jacobs AJ; Blessing JA; Munoz A
    Gynecol Oncol; 1992 Mar; 44(3):268-70. PubMed ID: 1541440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS; Blessing JA; Boike G
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Thigpen T; Shingleton H; Homesley H; Lagasse L; Blessing J
    Cancer; 1981 Aug; 48(4):899-903. PubMed ID: 7196794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Rose PG; Blessing JA; Arseneau J
    Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
    Lincoln S; Blessing JA; McGehee R; Lentz SS
    Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Malfetano JH; Blessing JA; Homesley HD; Look KY; McGehee R
    Am J Clin Oncol; 1996 Apr; 19(2):184-6. PubMed ID: 8610646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Thigpen JT; Ehrlich CE; Conroy J; Blessing JA
    Am J Clin Oncol; 1983 Aug; 6(4):427-30. PubMed ID: 6869315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
    Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
    Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study.
    Marshall ME; Wolf MK; Crawford ED; Taylor S; Blumenstein B; Flanigan R; Meyers FJ; Hynes HE; Barlogie B; Eisenberger M
    Invest New Drugs; 1993; 11(2-3):207-9. PubMed ID: 8262733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of echinomycin.
    Pazdur R; Haas CD; Baker LH; Leichman CG; Decker D
    Cancer Treat Rep; 1987 Dec; 71(12):1217-9. PubMed ID: 3690532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Thigpen JT; Blessing J; Homesley HD; Adcock LL
    Am J Clin Oncol; 1983 Aug; 6(4):423-6. PubMed ID: 6688150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Feun LG; Blessing JA; Barrett RJ; Hanjani P
    Am J Clin Oncol; 1993 Dec; 16(6):506-8. PubMed ID: 8256767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Look KY; Blessing JA; Muss HB; Partridge EE; Malfetano JH
    Am J Clin Oncol; 1992 Dec; 15(6):497-9. PubMed ID: 1449112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.